Vaxzevria significantly boosted antibody levels against Omicron

University of Oxford study supports use of Vaxzevria as third dose booster against Omicron Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant AstraZeneca’s Read More …

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study

Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19 In this pre-clinical study, Evusheld’s Inhibitory Concentration 50 (IC50), a measure of neutralising potency of an antibody, was 171 ng/ml and 277 ng/ml in two confirmatory tests, which is within the Read More …

30 million vaccine doses delivered to Vietnam via AstraZeneca-VNVC partnership

AstraZeneca and Vietnam Vaccine JSC (VNVC) have delivered an additional 1,547,100 doses of COVID-19 Vaccine AstraZeneca (also known as Vaxzevria) to Vietnam, reaching the milestone of 30 million doses and completing the first phase of the companies’ vaccine supply partnership, Read More …

Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

Only antibody therapy authorised in US for pre-exposure prophylaxis   Pivotal phase III data showed robust efficacy and long-term protection with one dose in high-risk population  AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency Read More …

More than 1.2 million doses of AstraZeneca’s COVID-19 vaccine arrive in Vietnam

Vietnam Prime Minister and AstraZeneca CEO had bilateral telephone conversation today AstraZeneca delivered another 1,209,400 doses of its COVID-19 vaccine to Vietnam. The delivery is the ninth to Vietnam in total as part of the advance purchase agreement (APA) between Read More …

Almost 600,000 additional doses of AstraZeneca’s COVID-19 vaccine arrive in Vietnam

AstraZeneca delivered 592,100 additional doses of its COVID-19 vaccine for use in Vietnam on August 6th, 2021. The delivery is the seventh to Vietnam in total as part of the advance purchase agreement between AstraZeneca and Vietnam Vaccine JSC (VNVC), Read More …

First COVID-19 variant vaccine AZD2816 Phase II/III trial participants vaccinated

Trial to enroll approximately 2,250 adults to assess safety and immunogenicity of AZD2816 against the SARS-CoV-2 virus The first participants in a Phase II/III trial for the new COVID-19 variant vaccine AZD2816 were vaccinated today to assess its safety and immunogenicity in both Read More …

Healthcare industry offers fresh opportunities in the “new normal”

MDIS Partners with Northumbria University, UK to offer Healthcare Management & Public Health Master’s Degree Qualifications for Healthcare Practitioners! COVID-19 has changed the daily lives of many as every country and industry prepares to enter a “new normal” where people Read More …